Treatment Outcomes and Prognostic Factors in 66 Patients with Chronic Myelomonocytic Leukemia (CMML) in a Single Center

INTRODUCTION: Chronic myelomonocytic leukemia (CMML) is a rare hematological malignancy bearing of both myelodysplastic syndrome and myeloproliferative neoplasm characteristics. Despite the low incidence, the clinical diagnosis of CMML was difficult and the survival was poor. The optimal first-line...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao, Wang, Zhiqiong, Meng, Fankai, Luo, Li, Liu, Xian, Shi, Jiayu, Huang, Lifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835103/
https://www.ncbi.nlm.nih.gov/pubmed/36644378
http://dx.doi.org/10.2147/IJGM.S371766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835103/
https://www.ncbi.nlm.nih.gov/pubmed/36644378
http://dx.doi.org/10.2147/IJGM.S371766

Ejemplares similares